S-(Pyrimidin-2-yl)quinoline-2-carbothioate

ID: ALA5184362

PubChem CID: 168282541

Max Phase: Preclinical

Molecular Formula: C14H9N3OS

Molecular Weight: 267.31

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Sc1ncccn1)c1ccc2ccccc2n1

Standard InChI:  InChI=1S/C14H9N3OS/c18-13(19-14-15-8-3-9-16-14)12-7-6-10-4-1-2-5-11(10)17-12/h1-9H

Standard InChI Key:  PEKXORRZBWQMCT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.7853    1.0270    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7853    0.2020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4964   -0.2163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2093    0.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2093    1.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5003    1.4336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0723   -0.2045    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.3637    0.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3637    1.0303    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3491   -0.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0651    0.2225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7836   -0.1908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7836   -1.0189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0721   -1.4336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3491   -1.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4947   -1.4287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2093   -1.0189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2093   -0.1908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4947    0.2273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  2  7  1  0
  8  7  1  0
  8  9  2  0
 10  8  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 13 14  1  0
 10 15  1  0
 15 14  2  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 12 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5184362

    ---

Associated Targets(Human)

Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

rep Replicase polyprotein 1ab (11336 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero 76 (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 267.31Molecular Weight (Monoisotopic): 267.0466AlogP: 2.96#Rotatable Bonds: 2
Polar Surface Area: 55.74Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.57CX LogP: 3.21CX LogD: 3.21
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.53Np Likeness Score: -1.18

References

1. Pillaiyar T, Flury P, Krüger N, Su H, Schäkel L, Barbosa Da Silva E, Eppler O, Kronenberger T, Nie T, Luedtke S, Rocha C, Sylvester K, Petry MRI, McKerrow JH, Poso A, Pöhlmann S, Gütschow M, O'Donoghue AJ, Xu Y, Müller CE, Laufer SA..  (2022)  Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination.,  65  (13.0): [PMID:35709506] [10.1021/acs.jmedchem.2c00636]

Source